Hirasawa Y - Search Results

1

Antiplatelet activities of FK409, a new spontaneous NO releaser.

Kita Y, Hirasawa Y, Yoshida K, Maeda K. Kita Y, et al. Among authors: hirasawa y. Br J Pharmacol. 1994 Oct;113(2):385-8. doi: 10.1111/j.1476-5381.1994.tb17000.x. Br J Pharmacol. 1994. PMID: 7834188 Free PMC article.

2

A new nitric oxide (NO) releaser: spontaneous NO release from FK409.

Fukuyama S, Kita Y, Hirasawa Y, Azuma T, Sato A, Morokoshi N, Koda S, Yasuda T, Oka S, Sakurai H. Fukuyama S, et al. Among authors: hirasawa y. Free Radic Res. 1995 Nov;23(5):443-52. doi: 10.3109/10715769509065265. Free Radic Res. 1995. PMID: 7581827

3

Comparison of antiplatelet effects of FK409, a spontaneous nitric oxide releaser, with those of TRK-100, a prostacyclin analogue.

Hirasawa Y, Nishio M, Maeda K, Yoshida K, Kita Y. Hirasawa Y, et al. Eur J Pharmacol. 1995 Jan 5;272(1):39-43. doi: 10.1016/0014-2999(94)0062s-5. Eur J Pharmacol. 1995. PMID: 7713147

4

FR144420, a novel, slow, nitric oxide-releasing agent.

Kita Y, Ohkubo K, Hirasawa Y, Katayama Y, Ohno M, Nishino S, Kato M, Yoshida K. Kita Y, et al. Among authors: hirasawa y. Eur J Pharmacol. 1995 Mar 6;275(2):125-30. doi: 10.1016/0014-2999(94)00750-2. Eur J Pharmacol. 1995. PMID: 7796846

5

Close correlation of the cardioprotective effect of FK409, a spontaneous NO releaser, with an increase in plasma cyclic GMP level.

Kita Y, Sugimoto T, Hirasawa Y, Yoshida K, Maeda K. Kita Y, et al. Among authors: hirasawa y. Br J Pharmacol. 1994 Sep;113(1):5-6. doi: 10.1111/j.1476-5381.1994.tb16165.x. Br J Pharmacol. 1994. PMID: 7812632 Free PMC article.

6

Antianginal effects of FK409, a new spontaneous NO releaser.

Kita Y, Ozaki R, Sakai S, Sugimoto T, Hirasawa Y, Ohtsuka M, Senoh H, Yoshida K, Maeda K. Kita Y, et al. Among authors: hirasawa y. Br J Pharmacol. 1994 Dec;113(4):1137-40. doi: 10.1111/j.1476-5381.1994.tb17115.x. Br J Pharmacol. 1994. PMID: 7889266 Free PMC article.

7

Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409.

Kita Y, Hirasawa Y, Maeda K, Nishio M, Yoshida K. Kita Y, et al. Among authors: hirasawa y. Eur J Pharmacol. 1994 May 12;257(1-2):123-30. doi: 10.1016/0014-2999(94)90703-x. Eur J Pharmacol. 1994. PMID: 8082692

8

Oral biological activities of spontaneous nitric oxide releasers are accounted for by their nitric oxide-releasing rates and oral absorption manners.

Kita Y, Hirasawa Y, Fukuyama S, Ohkubo K, Kato Y, Takamatsu H, Ohno M, Nishino S, Kato M, Seki J. Kita Y, et al. Among authors: hirasawa y. J Pharmacol Exp Ther. 1996 Feb;276(2):421-5. J Pharmacol Exp Ther. 1996. PMID: 8632305

9

Acceleration of nitric oxide (NO) release from FK409, a spontaneous NO releaser, in the presence of sulfhydryl-bearing compounds.

Fukuyama S, Hirasawa Y, Cox D, Koda S, Kita Y. Fukuyama S, et al. Among authors: hirasawa y. Pharm Res. 1995 Dec;12(12):1948-52. doi: 10.1023/a:1016248124104. Pharm Res. 1995. PMID: 8786971

10

Antianginal effects of FR144420, a novel slow nitric oxide-releasing agent.

Hirasawa Y, Sugimoto T, Fukuyama S, Kato Y, Takamatu H, Ohno M, Nishino S, Kato M, Maeda K, Seki J, Kita Y. Hirasawa Y, et al. Eur J Pharmacol. 1996 May 6;303(1-2):55-9. doi: 10.1016/0014-2999(96)00105-7. Eur J Pharmacol. 1996. PMID: 8804911

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

674 results

Search Page